Financial statements are reported in CAD and shown here converted to USD at today's exchange rate.
CGC — Canopy Growth Corporation
$0.56
$-0.01 (-2.20%)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Market Cap
$252.32M
Forward P/E
-3.3x
52-Week Range
N/A
CGC Price History
Revenue vs. Net Income
$199M
Revenue · FY2026
Annual. Net margin is shown under each year.
Free Cash Flow
-$48.9M
FCF · FY2026
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-23.4%
ROCE · FY2026
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.7x
Assets ÷ liabilities · FY2026
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
2.1%
CapEx · FY2026
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+177.1%
Dilution · FY2026
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
